Neochem Bio Solutions Reports Strong H1 FY27 Results Driven by Specialty Chemical Expansion
Neochem Bio Solutions Ltd 路 Investor Presentation 路 29 Oct 2026, 5:52 pm
Neochem Bio Solutions Reports Strong H1 FY27 Results Driven by Specialty Chemical Expansion Neochem Bio Solutions reported a 50% YoY increase in revenue from operations to INR 68.9 crore for H1 FY27, with EBITDA rising 25% YoY to INR 12.4 crore (18.0% margin) and PAT growing 43% YoY to INR 7.8 crore (11.3% margin). Capacity utilization reached 61.8% at its 22,000 MTPA facility. Cash conversion cycle improved to 212 days from 246 days in FY26, while net debt-to-equity stood at 0.38x. Non-textile diversification advanced, with Home & Personal Care revenue expanding 35% YoY to INR 9.8 crore.
Original exchange filing (PDF)
More announcements from Neochem Bio Solutions Ltd
- Neochem Bio Solutions Limited has informed the Exchange about Transcript 路 03 Nov 2026
- Neochem Bio Solutions Limited has informed the Exchange about Link of Recording 路 30 Oct 2026
- Neochem Bio Solutions Limited has submitted to the Exchange, the Unaudited Half Yearly financial results for the period ended September 30, 2026. 路 28 Oct 2026
- Neochem Bio Solutions Limited has informed the Exchange about Schedule of meet 路 27 Oct 2026
- NEOCHEM BIO SOLUTIONS LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 27 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 27 Oct 2026
- Neochem Bio Solutions has submitted Statement of Investor Grievances under Reg. 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2026. 路 20 Oct 2026
- Neochem Bio Solutions Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter and half year ended on 30th September, 2026 路 20 Oct 2026
